The prognostic roles of cyclooxygenase-2 for patients with basal cell carcinoma

References

• Sobjanek M, Zablotna M, Michajlowski I, et al. 308 G/A TNF-alpha gene polymorphism influences the course of basal cell carcinoma in a Polish population. Arch Med Sci. 2015;11:599–604.
   PubMed Web of Science ®Google Scholar
• Ballester-Sanchez R, Pons-Llanas O, Candela-Juan C, et al. Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma. J Contemp Brachytherapy. 2015;7:231–238.
   PubMed Web of Science ®Google Scholar
• Bobadilla F, Wortsman X, Munoz C, et al. Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology. Cancer Imaging. 2008;8:163–172.
   PubMed Web of Science ®Google Scholar
• Al-Niaimi F, Sheth N, Kurwa HA, et al. Photodynamic therapy followed by Mohs micrographic surgery compared to Mohs micrographic surgery alone for the treatment of basal cell carcinoma: results of a pilot single-blinded randomised controlled trial. J Cutan Aesthet Surg. 2015;8:88–91.
   PubMedGoogle Scholar
• Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol. 2006;35:1514–1521.
   PubMed Web of Science ®Google Scholar
• Lock-Andersen J, Drzewiecki KT, Wulf HC. Naevi as a risk factor for basal cell carcinoma in Caucasians: a Danish case-control study. Acta Derm Venereol. 1999; 79:314–319.
   PubMed Web of Science ®Google Scholar
• Lock-Andersen J, KT and Wulf D. HC. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish Case-Control Study. Acta Derm Venereol. 1999;79:74–80.
   PubMed Web of Science ®Google Scholar
• Kaur P, Mulvaney M, Carlson JA. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis. Am J Dermatopathol. 2006;28:293–307.
   PubMed Web of Science ®Google Scholar
• Kaporis HG, Guttman-Yassky E, Lowes MA, et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol. 2007;127:2391–2398.
   PubMed Web of Science ®Google Scholar
• Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327:794–798.
   PubMed Web of Science ®Google Scholar
• Bath-Hextall FJ, Perkins W, Bong J, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;CD003412.
   PubMed Web of Science ®Google Scholar
• Dixon AY, Lee SH, McGregor DH. Histologic evolution of basal cell carcinoma recurrence. Am J Dermatopathol. 1991;13:241–247.
   PubMed Web of Science ®Google Scholar
• de Rosa G, Vetrani A, Zeppa P, et al. Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer. 1990;65:544–549.
   PubMed Web of Science ®Google Scholar
• Wang JL, Wang X, Yang D, et al. Association between 8473T > C polymorphism in the cyclooxygenase-2 gene and the risk of nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2015;8:7441–7445.
   PubMed Web of Science ®Google Scholar
• Mitsudomi T, Suda K, Yatabe Y. Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol. 2013;10:235–244.
   PubMed Web of Science ®Google Scholar
• Allaj V, Guo C, Nie D. Non-steroid anti-inflammatory drugs, prostaglandins, and cancer. Cell Biosci. 2013; 3: 8
   PubMed Web of Science ®Google Scholar
• Chow LW, Yip AY, Loo WT, et al. Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer. J Steroid Biochem Mol Biol. 2008;111:13–17.
   PubMed Web of Science ®Google Scholar
• Jana D, Sarkar DK, Ganguly S, et al. Role of cyclooxygenase 2 (COX-2) in prognosis of breast cancer. Indian J Surg Oncol. 2014;5:59–65.
   PubMedGoogle Scholar
• Chell S, Kaidi A, Williams AC, et al. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochim Biophys Acta. 2006;1766:104–119.
   PubMed Web of Science ®Google Scholar
• Chu AJ, Chou TH, Chen BD. Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications. Front Biosci. 2004;9:2697–2713.
   PubMed Web of Science ®Google Scholar
• El-Khalawany MA, Abou-Bakr AA. Role of cyclooxygenase-2, ezrin and matrix metalloproteinase-9 as predictive markers for recurrence of basal cell carcinoma. J Can Res Ther. 2013;9:613–617.
   PubMed Web of Science ®Google Scholar
• Tjiu JW, Liao YH, Lin SJ, et al. Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis. J Invest Dermatol. 2006;126:1143–1151.
   PubMed Web of Science ®Google Scholar
• Park MK, Ko EJ, Jeon KY, et al. Induction of angiogenesis by malarial infection through hypoxia dependent manner. Korean J Parasitol. 2019;57:117–125.
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.
   PubMed Web of Science ®Google Scholar
• Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg. 2005;9:10–15.
   PubMed Web of Science ®Google Scholar
• Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008;9:1149–1156.
   PubMed Web of Science ®Google Scholar
• Adegboyega PA, Rodriguez S, McLarty J. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma. Hum Pathol. 2010;41:1128–1137.
   PubMed Web of Science ®Google Scholar
• Janisson-Dargaud D, Durlach A, Lorenzato M, et al. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma. J Cutan Pathol. 2008;35:916–921.
   PubMed Web of Science ®Google Scholar
• Lau MT, Wong AS, Leung PC. Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells. Endocrinology. 2010;151:2985–2993.
   PubMed Web of Science ®Google Scholar
• Gangwar R, Mandhani A, Mittal RD. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India. Surgery. 2011;149:126–134.
   PubMed Web of Science ®Google Scholar
• Chen Z, Yang J, Huang Q. Correlation and expression of COX-2 and P53 protein in basal cell carcinoma of eyelid. J Huazhong Univ Sci Technol Med Sci. 2009;29:383–386.
   PubMedGoogle Scholar
• Karagece Yalcin U, Seckin S. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases. Turk Patoloji Derg. 2012;28:119–127.
   PubMedGoogle Scholar
• Tjiu JW, Chen JS, Shun CT, et al. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol. 2009;129:1016–1025.
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene. 2010;29:781–788.
   PubMed Web of Science ®Google Scholar
• Ogino S, Kirkner GJ, Nosho K, et al. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res. 2008;14:8221–8227.
   PubMed Web of Science ®Google Scholar
• Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002;62:632–635.
   PubMed Web of Science ®Google Scholar